The role of Notch signaling in human innate lymphoid cell (ILC) differentiation is unclear, although IL-7 and IL- 15 I nnate lymphoid cells (ILCs) are innate immune cells of lymphoid origin that lack expression of Ag receptors, but retain pivotal effector and regulatory functions for innate immunity and tissue homeostasis (1) . In addition to conventional NK (cNK) cells, ILCs are classified into three additional groups based on their discrete patterns of cytokine production in response to particular stimulation signals and their distinct requirements of transcription factors (TFs) for their development and functional maintenance (2) (3) (4) . Group 3 ILCs (ILC3s) are characterized by the expression of the retinoic acid receptor-related orphan receptor (ROR)gt TF and the production of IL-17 and/or IL-22 (5, 6) . Furthermore, the aryl hydrocarbon receptor (AHR) is required for the postnatal differentiation of mouse ILC3s (7) (8) (9) . Human ILC3s can be further divided into three subsets: lymphoid tissue inducer cells, natural cytotoxicity receptor (NCR) NKp44 + ILC3s, and NKp44 2 ILC3s. Human RORgt + NCR + ILC3s, as well as cNK cells, differentiate simultaneously from cord blood (CB) CD34 + hematopoietic progenitor cells (HPCs) in the presence of IL-7 and IL-15 (10) . RORgt + CD34 dim cells residing in human tonsils (To) and intestinal lamina propria (LP) can specifically differentiate into ILC3s, whereas RORgt 2 CD34 + cells have the potential to differentiate into both ILC3 and cNK cells (11) . Although these studies demonstrated that ILC3 potential is preserved in human HPCs, the transcriptional regulation involved in the differentiation of ILC3s from HPCs, particularly lineage divarication from cNK cells, is largely unknown.
The developmental program of ILCs has been studied extensively in mice (3) . The presence of common innate lymphoid progenitors at the downstream stage of common lymphoid progenitors was predicted by the finding that mice lacking expression of the transcriptional regulatory inhibitor of DNA binding 2 (Id2) have a loss of all ILC lineages, whereas T and B cell development is largely unaffected (12) (13) (14) . In Id2 reporter mice, a single Id2 + cell with the CD127 + Flt-3 2 CD25 2 integrin a 4 b 7 + phenotype gave rise to all ILC lineages, but not to cNK cells (15) , suggesting that this Id2 + progenitor cell functions as a common helper-like ILC progenitor (CHILP) (3) without cNK cell potential. Furthermore, the promyelocytic leukemia zinc finger TF is partly involved in the development of CHILP (15, 16) .
In addition to Id2 and its potential target gene promyelocytic leukemia zinc finger TFs, Notch signals are a major common denominator in ILC lineage differentiation in mice. CHILP generates progeny of all ILC lineages following coculture with OP9 stroma cells that express Notch ligand delta-like 1 (OP9-DL1) (15) . ILC1s and NCR + ILC3s are greatly decreased in mice lacking the Notch signaling adaptor RBP/J (17) . In vivo and in vitro development of ILC2s requires Notch signals (18, 19) . ILC3 differentiation also requires Notch signals, although the requirement is different in fetal and adult progenitors (14, 20) . Acquisition of T-box expressed in T cells (T-bet) expression, which is required for NCR + ILC3 differentiation, also requires Notch stimulation by OP9-DL1 stroma cells (21) . Recent studies have shown that Notch signaling is required for differentiation of NCR + ILC3 from NCR 2 ILC3 and for maintenance of the NCR + ILC3 population (22, 23) . In humans, Notch signals enhance cNK cell differentiation from HPCs in culture (24) (25) (26) (27) . However, although only one report noted that ILC2 lineage cells can be induced from postnatal thymic CD34 + CD1a 2 cells by Notch signals using OP9-DL1 cells (28) , the significance of Notch signaling in the commitment of human ILCs is largely unknown.
In the present study, we clarified the functions of Notch in the differentiation of human NCR + ILC3s and cNK cells from human HPCs circulating in peripheral blood (PB). A recent report using parabiotic mice demonstrated that ILCs in both lymphoid and nonlymphoid organs were locally renewed and expanded in response to acute infection (29) . However, although the homeostasis and lifespan of human ILCs in peripheral organs are totally unknown, we assume that ILC precursors migrate from bone marrow (BM) to peripheral organs through the bloodstream in adults, particularly during severe epithelial damage in association with an extensive shrinkage of the ILC pool. We previously developed a cell sorting-based limiting dilution assay (LDA) and clonal analyses using coculture with OP9-DL1 cells in 384-well microplates for quantification and characterization of various progenitors among CD34 + HPC populations circulating in PB of adult humans (26, 30) . LDA and clonal assays are thought to be essential for accurate quantification of lineage commitment in a specific progenitor population, because extensive generation of progeny that originate from a limited number of highly proliferative progenitor clones skews experimental output. In this study, we further improved the LDA and clonal assay with high-throughput flow cytometry (HTFC) (31) 
Materials and Methods

Cytokines and Abs
Recombinant human Kit ligand (KL), Flt-3 ligand (FL), IL-1b, and IL-7 were purchased from PeproTech. IL-12p70 and IL-15 were purchased from Tonbo Biosciences. IL-18 and IL-23 were purchased from MBL International and eBioscience, respectively.
Anti-CD3 (UCHT1), CD7 (CD7-6B7), CD11a (TS2/4 and HI111), CD11c (Bu15), CD14 (M5E2), CD15 (H198 and W6D3), CD16 (3G8), CD19 (HIB19), CD20 (2H7), CD34 (581), CD56 (HCD56), CD62L (DREG-56), CD117 (104D2), CD135 (BV10A4H2), CD161 (HP-3G10), CD235a (HI235), CD294 (BM16), NKp44 (P44-8), NKp46 (9E2), IL-8 (E8N1), and IL-17A (BL168) Abs and human IgG1 isotype control (ET901) were purchased from BioLegend. Anti-CD3 (SK7), CD5 (UCHT2), CD7 (M-T701), CD16 (3G8), CD235a (GA-R2), HLA-DR (L243), and IFN-g (25723.11) Abs were purchased from BD Biosciences. Anti-CD16a (3G8), CD56 (N901), CD159a (Z199), and CD314 (ON72) Abs were purchased from Beckman Coulter. Anti-CD10 (CB-CALLA), CD14 (61D3), CD25 (BC96), IL-22 (22URTI), GM-CSF (GM2F3), RORgt (AFKJS-9), AHR (FF3399), T-bet (eBio4B10), and eomesodermin (Eomes; WD1928) Abs were obtained from eBioscience. Anti-CD25 (BC96), CD45RA (HI100), and CD127 (R34-34) Abs were purchased from Tonbo Biosciences. Anti-CD14 (T € UK4) and granzyme B (GB12) Abs were purchased from Invitrogen. Anti-Notch1 NRR (NRR1) and anti-Notch2 NRR (NRR2) Abs were provided by C.W. Siebel (Genentech, South San Francisco, CA). Development and characterization of anti-NRR1 and anti-NRR2 Abs were as described elsewhere (33) .
Preparation of PB HPCs
Human PB samples were collected from 11 healthy in-house volunteer donors (Japanese) with informed consent (5 males and 6 females; age range, 38-61 y), following the guidance of the Institutional Review Board (Human Investigation Committee of the Radiation Effects Research Foundation), which approved this study. PBMCs were separated from 10-ml PB samples by Ficoll density gradient centrifugation (lymphocyte separation medium 1077; Wako Pure Chemical Industries). For sorting CD34 + lineage (Lin) 2 CD7 2 HPCs, PBMCs were stained with allophycocyanin-labeled anti-CD34, PerCP-Cy5.5-labeled anti-CD7, and PE-labeled anti-lineage marker (CD3, CD14, CD15, CD16, CD19, CD20, CD56, and CD235a) Abs for 30 min on ice, and dead cells were excluded by 1 mg/ml DAPI (Invitrogen). CD34 
Stroma cells
Generation of mouse OP9-DL1 stroma cells from OP9 cells (34) engineered to express the GFP and mouse DL1 has been described previously (35) . OP9-DL1 and the OP9 stroma cells were maintained by culturing in aMEM (Life Technologies) supplemented with 20% FBS (Hyclone), 4 3 10 26 M 2-ME, and penicillin-streptomycin at 37˚C in a humidified atmosphere of 5% CO 2 .
Coculture of HPCs with stroma cells
Details of the methods of HPC coculture with stroma cells were as described previously (26) . Briefly, OP9-DL1 or OP9 stroma cells were seeded in the wells of a 24-well plate or 384-well flat-bottom black plate (BD Biosciences), which were coated with gelatin. Briefly, at least 4 h prior to HPC sorting, culture medium in each well was replaced with 50 ml of phenol red-free aMEM containing 20% knockout serum replacement (Life Technologies), 10 24 M monothioglycerol (Sigma-Aldrich), 50 mg/ml gentamicin (Sigma-Aldrich), KL and FL in combination with IL-7 and/or IL-15 (10 ng/ml). For bulk culture of HPCs, HPCs and their subpopulation cells were cocultured with stroma cells in a 24-well plate at a density of $500 HPCs per well for 2-5 wk.
Surface phenotyping of ILCs and cNK cells
For surface phenotyping of progeny harvested from coculture of HPCs with stroma cells, cells were stained with PE-Cy7-labeled anti-CD56, allophycocyanin-Cy7-labeled CD16, allophycocyanin-labeled or PE-labeled CD11a, and PerCP-Cy5.5-labeled or PE-labeled CD7 Abs, in combination with PerCP-Cy5.5-labeled CD161, PE-labeled anti-NKG2A, PE-labeled anti-NKp44, PerCP-Cy5.5-labeled anti-NKp46, allophycocyanin-labeled anti-c-Kit, allophycocyanin-labeled anti-CD25, and allophycocyaninlabeled anti-CD127 Abs. For detection of CD127 expression, progeny were precultured in the absence of IL-7 for 5 d.
Cytoplasmic and nuclear immunostaining
For detection of intracellular cytokines, ILC3 (CD56 + CD11a
2 ) and cNK cells (CD56 + CD11a + ) sorted from coculture of HPCs with stroma cells as described above were stimulated with either IL-1b and IL-23 or IL-12 and IL-18 for 12 h in the absence of stroma cells in U-bottom 96-well plates (BD Biosciences). After cytokine stimulation, cells were treated with brefeldin (eBioscience) for 4 h to inhibit the protein transporter, and cells were harvested and stained with a Zombie Green fixable viability kit (BioLegend) to gate out dead cells by flow cytometry. Cells were stained with allophycocyanin-conjugated anti-CD11a, PE-Cy7-conjugated anti-CD56, and PerCP-Cy5.5-conjugated anti-CD7 Abs for 30 min on ice and washed with PBS. Fixation and permeabilization of cells were performed using an intracellular fixation and permeabilization buffer set (eBio). Fixed and permeabilized cells were stained with PE-conjugated anti-IL-8, IL-17, IL-22, GM-CSF, and IFN-g Abs.
For detecting expression of TFs, sorted ILC3 and cNK cells were stained with Zombie Green and stained with anti-CD7, CD56, and CD11a Abs, as described above. Fixation and permeabilization of cells were performed using a Foxp3 TF staining buffer set (eBioscience). Fixed and permeabilized cells were stained with PE-conjugated anti-RORgt, AHR, T-bet, and Eomes Abs. Flt-3 2 c-Kit low HPC subpopulations, HPCs were sorted at six, four, two, and one cell per well. LDA culture was maintained at 37˚C in a humidified atmosphere of 5% CO 2 , and half the culture medium (25 ml) was changed every week. After 3-5 wk of culture, all cells grown in wells of the 384-well plate were harvested by vigorous pipetting and transferred to a 96-well plate. For detection of NCR + ILC3 and cNK cell lineage progeny, harvested progeny cells were stained with PE-Cy7-labeled anti-CD56, PerCP-Cy5.5-labeled anti-CD7, PE-labeled anti-CD11a, allophycocyanin-labeled anti-NKp44, and allophycocyanin-Cy7-labeled CD16 Abs in PBS containing 2 mM EDTA, 0.01% NaN 3 , and 1% FBS (washing buffer [WB] ). For detection of T and myeloid cells, progeny were stained with PE-labeled anti-CD7, allophycocyanin-labeled anti-CD5, PECy7-labeled anti-CD56, allophycocyanin-Alexa Fluor 750-labeled CD14, and PerCP-Cy5.5-labeled anti-CD15 Abs. When cell samples were assayed for both ILC3/cNK and T/myeloid cells, cell suspensions were split into two 96-well plates for staining with each Ab set. After washing cells with WB, all stained cells suspended in 30 ml of WB containing DAPI were aspirated and transferred to a CyAn (Beckman Coulter) flow cytometer by HyperCyt (IntelliCyt) (31) . The tubing line was washed with Triton X-100 (2%) and WB after each sampling of cells from wells to avoid cross contamination of cell samples between wells. A well exhibiting six or more positive events was designated as a positive well for LDA. When cell samples were assayed for both ILC3/cNK and T/myeloid cells, a well exhibiting three or more positive events was considered positive. Responding progenitor frequencies (PFs) of ILC3, cNK, and T cells were calculated by online analysis using ELDA software (36) , available on the home page of Walter and Eliza Hall Institute Bioinformatics Division (http://bioinf.wehi.edu.au/software/elda/index.html). The 95% confidence interval of each PF and the p values of the differences in PFs between two different culture conditions were obtained by this software.
Limiting dilution and single-cell analyses by HTFC
For clonal HPC assays, total HPCs and their subpopulation cells were sorted into 160 wells of a 384-well plate at one cell per well. The methods of OP9-DL1 coculture and flow cytometry of progeny for clonal HPC culture were the same as for LDA as described above.
Inhibition of Notch functions by anti-NRR Abs
Anti-NRR1, anti-NRR2, or human isotype control IgG 1 was added to the coculture of HPC subpopulations with OP9-DL1 stroma cells at the initiation of culture. The optimum concentration of Abs (10 mg/ml) was determined by preliminary dose response experiments (data not shown). Effects of Abs on generation of NCR + ILC3, cNK cell, and T cell progenies from HPCs were evaluated by LDA, as described above. We further analyzed the surface phenotype of ILC3 and cNK cell progeny generated under the different conditions. As shown in IL-7(+)IL-15 and (+)NL/(+)IL-7(2)IL-15 conditions expressed high levels of c-Kit and NKp44 and significant levels of CD161, CD127, and CD25, but no CD314 (NKG2D) or CD16. In contrast, CD56 + CD11a + progeny generated in the presence of IL-15 exhibited significant levels of CD314 and CD16 but no CD127 expression (Fig. 2, Supplemental Fig. 1B) , whereas CD56 + CD11a + progeny generated under (+)NL/(+)IL-7/(2)IL-15 conditions exhibited immature phenotypes such as a significant level of CD127, but only low levels of CD314 and CD16 expression (Fig. 2) (Fig. 3A) . Again, most NKp44 + ILC3 and cNK cell progeny were CD7 2 and CD7 + , respectively. Notch signaling in combination with IL-7 stimulated ILC3 commitment of total HPCs, even in the absence of IL-15 (p = 0.00029), whereas this signal was not required for ILC3 differentiation in the presence of IL-15 (Fig. 3B, upper) , as observed in the bulk culture (Fig. 1) . Moreover, Notch stimulated IL-7-induced cNK cell differentiation (p = 0.011), as reported by our previous studies (26, 30) . In contrast, Notch signaling significantly suppressed cNK cell commitment induced by IL-15 (p , 10 25 ) (Fig. 3B, lower) . The differing actions of Notch signaling on NCR + ILC3 and cNK cell commitments observed in the total HPC population were thought to be attributable to the differences in Notch functions in different HPC subpopulations. (38) . Thus, HPC-3 progenitors may be a novel HPC subpopulation detected only in adult PB, although the population size was relatively small (Fig. 4A) . NCR + ILC3 and cNK cell PFs of each subpopulation were determined by LDA using HTFC (Fig. 4B, 4C) . The opposite effects of Notch signaling on IL-7-induced NCR + ILC3 versus IL-15-induced cNK cell commitments observed in the total HPCs (Fig. 3B) were most prominent in the HPC-3 subpopulation (p , 10 25 ) (Fig. 4B,  4C) . In this subpopulation, IL-7 was more effective than IL-15 for Notch-dependent NCR + ILC3 differentiation (p = 0.0030), whereas IL-15 was more effective for Notch-independent cNK cell induction (p = 0.0046). Thus, the opposite effect of Notch on NCR + ILC3 and cNK cell commitment was observed, even in the presence of both IL-7 and IL-15. The HPC-2 subpopulation exhibited a similar characteristic as the HPC-3 subpopulations, but the suppressive effects of Notch on IL-15-induced cNK commitment were weaker in HPC-2 than in HPC-3 (Fig. 4C ) Thus, the opposite effects of Notch on NCR + ILC3 and cNK cell differentiation observed in the total HPCs can largely be attributed to the HPC-3 subpopulation. In contrast to HPC-2 and HPC-3 cells, Notch signaling significantly enhanced IL-7-induced NK cell generation in the HPC-1 subpopulation (p = 0.026), whereas the enhancement of IL-7-induced NCR + ILC3 generation by Notch stimulation was not significant in this subpopulation (p = 0.17) (Fig. 4C ) Hence, the enhancement of IL-7-induced cNK cell commitment observed in the total HPCs (Fig. 3B, lower) was attributable to the HPC-1 subpopulation. These findings suggest that Notch signaling works on the NCR (Fig. 5A ) and single-cell (Fig. 5B, 5C populations, respectively. Almost no T cell progeny were detected in the three HPC subpopulations in the absence of Notch signaling (data not shown). The linkage of lineage commitment was evaluated by clonal analyses of the HPC subpopulations. For these analyses, we detected NCR + ILC3, cNK cell, T cell, and myeloid cell progeny generated from a single HPC using HTFC (Fig. 5B, upper) and classified the lineage of the progeny (Fig. 5B, lower ; Supplemental Table I HPC-1, HPC-3 clones had ILC3 and/or NK cell potential but very low T and myeloid potential (Fig. 5B, lower) (Fig. 8A ) and evaluated their lymphoid and myeloid potential under (+)NL/(+)IL-7(+)IL-15 or (2)NL/(+)IL-7(+)IL-15 conditions by bulk cell cultures (Fig. 8A) and LDA (Fig. 8B) along with clonal analysis (Fig. 8C) .
Results
Differentiation of NCR
In the bulk culture, CD34 + Lin 2 CD7 + cells exhibited high cNK and T cell potential, but very low NCR + ILC3 potential in the presence of Notch signaling (Fig. 8A, left) (Fig. 8B) . Notably, in contrast to the suppressive effect of Notch signaling on cNK cell commitment in HPC-2 and HPC-3 subpopulations (Fig. 4C) , a stimulatory action of Notch on cNK cell differentiation was observed for CD34 + Lin 2 CD7 + cells (Fig. 8B) 
Effects of Notch Abs on lineage commitments in HPC subpopulations
Finally, we evaluated the effects of anti-NRR1 and anti-NRR2 Abs on the generation of NCR + ILC3s, cNK cell and T cell progenies from HPC subpopulations to determine whether Noch1 or Notch2 signals were required for the commitment of each lineage (Fig. 9) .
More than 60% of Notch-dependent generation of cNK cell progenies from the HPC-1 subpopulation was inhibited by either anti-NRR1 or anti-NRR2 Ab (Fig. 9A) . Each Ab also blocked .80% of Notch-dependent generation of T cells from HPC-1 cells. No significant additive effects between anti-NRR1 and anti-NRR2 Abs on the generation of both cNK and T cells were observed. This finding suggested that simultaneous signaling through both Nocth1 and Notch2 may be required for the commitment of cNK and T cell lineages in HPC-1 subpopulation.
sorted into the wells of 384-well plates and cultured in the presence or absence of Notch signaling with IL-7 and/or IL-15 for 3 wk. PFs and percentages are shown, as described in the legend for Fig. 3B . The p values of the differences in PFs between (+)NL (s) and (2) Similarly, nearly half of Notch-dependent NCR + ILC3 differentiation from HPC-3 cells was inhibited by either anti-NRR1 or anti-NRR2 Ab (Fig. 9A) . Conversely, Notch-dependent suppression of cNK cell generation from HPC-3 was found to be reverted by either Notch1 or Notch2 blockade. Interestingly, significant additive effects between anti-NRR1 and anti-NRR2 Abs were observed on both ILC3 generation and cNK cell suppression in HPC-3. This observation suggested that Notch1 and Notch2 signals may independently operate in the commitment in different subpopulations of HPC-3, which expressed either Notch1 or Notch2.
Because 
CD7
+ CD127 + cells, respectively, as described above (Figs. 6, 7, 8) , we tested the effect of anti-NRR1 and anti-NRR2 Abs 
CD127
+ from HPC-3 cells (Fig. 9B) . Thus, the inhibitory effects of Notch Abs on the differentiation of ILC3s, cNK cells, and T cells can be attributed to the suppression of intermediate cell formation from HPCs (Fig. 10) .
Discussion
In the present study, we demonstrated the crucial role of Notch signaling in the commitment of human adult circulating HPCs to the NCR + ILC3 or cNK cell lineage ex vivo. Notch functions had countervailing properties that stimulated IL-7-dependent NCR + ILC3 differentiation, but in turn suppressed IL-15-induced cNK cell differentiation in HPCs at large. These characteristics of Notch were most marked in the HPC-3 subpopulation, the differentiation potential of which was considerably inclined toward the NCR + ILC3 and cNK cell lineages as observed with LDA and clonal analysis. Thus, Notch signaling is thought to drive the innate lymphocyte progenitor toward the NCR + ILC3 commitment. Because the HPC-3 population had relatively high ILC3 and NK potential among HPC subpopulations, the countervailing functions of Notch observed in the total HPC population can mainly be attributed to those in the HPC-3 subpopulation. In contrast to Notch function in HPC-3 cells, Notch signaling enhanced IL-7-induced cNK cell but not NCR + ILC3 differentiation from the HPC-1 subpopulation. This enhancement of cNK cell differentiation was attributed to Notch dependency in the generation of CD34 + Lin 2 CD7 + cells that retained high cNK and T cell potentials but only minor NCR + ILC3 potential. Further stimulation of CD34 + Lin 2 CD7 + cells through Notch signaling promoted cNK cell differentiation, but not NCR + ILC3 differentiation. The HPC-2 subpopulation retained intermediate levels of ILC3 and cNK cell potential between those of HPC-1 and HPC-3 cells and exhibited similar Notch functions to HPC-3, although Notchdependent suppression of cNK cell commitment from HPC-2 was found to be weaker than that from HPC-3. These results suggest that Notch signaling plays pivotal roles in the fate decision of human HPC commitment to NCR + ILC3 or cNK cell lineages through the opposite functions at different stages of HPC differentiation, although the molecular mechanisms underlying the countervailing aspect of Notch signaling are unknown.
Notch signaling acted synergistically with IL-7 for cNK cell differentiation from the HPC-1 subpopulation and NCR + ILC3 cell differentiation from HPC-2 and HPC-3 subpopulations. In this context, Notch signaling is required for the expression of CD127
(IL-7R a-chain) in human early T cell progenitors (41, 42) , and IL-7R a-chain transduces IL-7 signals to promote cell survival as well as differentiation of CD4 2 CD8 2 double-negative thymocytes (43) . Analogous to T cell development, we presume that Notch signaling also induces IL-7R expression in cNK/ILC3 precursor cells. In fact, we found that Notch stimulation induced CD127 expression along with acquisition of CD7 and loss of CD34 expression in the HPC-1, HPC-2, and HPC-3 subpopulations. The induction of CD127 and CD7 expression in these cells was found to be independent of IL-7. Thus, these findings serve to primarily explain the synergistic interaction between Notch and IL-7 in NCR + ILC3 differentiation from HPC-2 and HPC-3. IL-7 signaling may promote cell survival and differentiation of NCR + ILC3 precursors. However, an additional, yet unanswered question is whether IL-7 signaling is sufficient for further ILC3 differentiation. Other Notch target genes should be investigated.
The interaction between Notch and IL-15 signals involved in NCR + ILC3 and cNK cell differentiation is thought to be different from the case of Notch and IL-7 in NCR + ILC3 differentiation. Although the presence of IL-15 produced an analogous trophic effect on ILC3 generation in all the HPC subpopulations in the absence of Notch signaling, this trophic effect of IL-15 was not significantly augmented by Notch signaling. Rather, Notch markedly suppressed IL-15-dependent differentiation of cNK cells from HPC-3 cells. Therefore, we primarily propose that Notch signaling suppresses the expression of the IL-15R required for cNK cell differentiation from HPC-3 cells. This hypothesis needs to be tested by quantification of IL-15R mRNA produced in these cells, as Abs with sufficient reactivity and specificity for detecting IL-15R in HPCs are not available at present. An alternative hypothesis is that Notch target genes may include TFs that suppress cNK cell differentiation. Because Notch signaling was shown to suppress Eomes expression in CD56 + CD11a
+ cells by the present study, a putative Notch-induced cNK cell repressor TF may suppress Eomes expression. In this context, it was reported that Notch signaling suppressed the expression of the Id2 NK cell program activator through the activation of the Bcl11b NK repressor at the double-negative stage 2 during early T cell development in mice (44) . In contrast to the suppressive function of Notch in IL-15-induced cNK cell differentiation from HPC-3 cells, Notch signaling augmented IL-7-induced cNK cell differentiation from HPC-1 cells, because a substantial proportion of the cNK cell population is generated from CD34 + Lin 2 CD7 + cells, which are induced from HPC-1 cells by Notch signaling. Similarly, Notch signaling was reported to induce cNK cell differentiation from human HPCs in culture (24, 26, 30, 45) (47) . It is known that Notch signaling is essential for T cell commitment in ETPs (32, 48) . In contrast, Notch signaling is dispensable for thymic NK cell differentiation in mice (49, 50 (32, 48) . Conversely, Notch2 can promote early T cell commitment of Notch1-deficient HSCs in coculture with OP9-DL1 stroma cells and possibly in vivo in the spleen after BM transplantation (32) . Thus, Notch2 compensates for the loss of Notch1 during mouse ETP generation in OP9-DL1 coculture, whereas Ab blocking of Notch1 signaling was found to almost completely inhibit human ETP generation in the present study. Such contradiction of ex vivo observation between mice and humans may reflect the difference in HSC characteristics in vivo between the two species. However, owing to the lack of human in vivo experimental systems in a physiological setting, a definitive conclusion is thought to be currently unob- HPC-3. In mice, although Notch2 signaling was reported to be required for in vivo differentiation of intestinal NCR + ILC3 from NCR 2 ILC3 and for maintenance of the NCR + ILC3 population (22, 23) , the development of intestinal NCR + ILC3 was not dependent on Notch signaling (22, 23) . We showed that human NCR + ILC3s were induced to some extent from the total HPC population or any HPC subpopulations by IL-15 in the absence of Notch signaling. It was also reported that differentiation of NCR + ILC3 from human To and intestinal LP CD34 + cells could be induced by a cytokine mixture containing IL-15 in the absence of Notch signaling ex vivo (11) . Thus, if this finding is also true for mice, it is presumed that the commitment of intestinal NCR + ILC3 in mice may be Notch-independent, but IL-15-dependent.
Considering our current findings, we propose a model for the differentiation pathways of NCR + ILC3 and cNK cells from human PB HPC subpopulations in the presence or absence of Notch signaling (Fig. 10) . HPC-1 is considered to contain an MPP population that retains at least ILC3, cNK, T, and myeloid potential, although the ILC3 potential was much lower than cNK and T cell potential even under (+)NL conditions. This may be be- + ILC3 and cNK cell potentials. Whether these ILC3 and cNK cell progeny are derived from a bipotential or distinctive monopotential HPC-3 clone is unclear, because most ILC3 and cNK cell progeny are exclusively generated under (+)NL or (2) NL culture conditions, respectively. Nevertheless, as under (+)NL culture conditions, a significant fraction of HPC-3 clones (∼10%) gave rise to both ILC3 and cNK cell progeny, being indicated that a portion of the HPC-3 population is likely bipotential. This HPC subpopulation may therefore be defined as common ILC3/cNK cell progenitors.
The HPC-3 subpopulation had similar phenotypes to To and intestinal LP CD34 + cells, which were reported to express CD45RA and differentiate to ILC3 and cNK cells (11) (Fig. 10) . If this is the case, ILC3/cNK cell precursors can be continuously supplied through PB from BM to the peripheral lymphoid organs in human adults. Further studies on the human To/LP microenvironment, including the distribution of NL-expressing cells, is needed to clarify whether Notch signaling is required for human ILC3 commitment in vivo.
In conclusion, we demonstrated that signaling functions of Notch play a crucial role in the fate decision of human circulating HPC subpopulations between ILC3 and cNK cell lineage commitments.
